Geode Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$891K Sell
437,549
-409,254
-48% -$833K ﹤0.01% 3364
2025
Q1
$1.38M Buy
846,803
+218,298
+35% +$356K ﹤0.01% 3189
2024
Q4
$1.15M Buy
628,505
+6,874
+1% +$12.6K ﹤0.01% 3322
2024
Q3
$3.59M Buy
621,631
+38,833
+7% +$224K ﹤0.01% 2923
2024
Q2
$4.71M Buy
582,798
+330,195
+131% +$2.67M ﹤0.01% 2764
2024
Q1
$3.51M Buy
252,603
+13,316
+6% +$185K ﹤0.01% 2878
2023
Q4
$1.46M Buy
239,287
+10,035
+4% +$61.4K ﹤0.01% 3203
2023
Q3
$1.07M Sell
229,252
-9,185
-4% -$42.9K ﹤0.01% 3290
2023
Q2
$1.28M Sell
238,437
-192,961
-45% -$1.03M ﹤0.01% 3258
2023
Q1
$4.24M Buy
431,398
+23,888
+6% +$235K ﹤0.01% 2710
2022
Q4
$7.63M Buy
407,510
+24,175
+6% +$453K ﹤0.01% 2437
2022
Q3
$7.94M Buy
383,335
+53,039
+16% +$1.1M ﹤0.01% 2400
2022
Q2
$6.86M Buy
330,296
+47,543
+17% +$987K ﹤0.01% 2513
2022
Q1
$12.2M Sell
282,753
-23,466
-8% -$1.01M ﹤0.01% 2217
2021
Q4
$18.3M Buy
306,219
+29,288
+11% +$1.75M ﹤0.01% 2012
2021
Q3
$23.8M Sell
276,931
-25,026
-8% -$2.15M ﹤0.01% 1836
2021
Q2
$33.6M Buy
301,957
+25,218
+9% +$2.81M ﹤0.01% 1625
2021
Q1
$30.8M Buy
276,739
+66,372
+32% +$7.39M ﹤0.01% 1586
2020
Q4
$22.3M Buy
210,367
+10,746
+5% +$1.14M ﹤0.01% 1649
2020
Q3
$27.8M Buy
199,621
+17,753
+10% +$2.47M 0.01% 1285
2020
Q2
$58.8M Buy
181,868
+41,496
+30% +$13.4M 0.01% 812
2020
Q1
$12.5M Buy
140,372
+27,782
+25% +$2.48M ﹤0.01% 1601
2019
Q4
$4.46M Buy
112,590
+4,866
+5% +$193K ﹤0.01% 2527
2019
Q3
$2.65M Buy
107,724
+7,761
+8% +$191K ﹤0.01% 2770
2019
Q2
$3.53M Buy
99,963
+5,695
+6% +$201K ﹤0.01% 2614
2019
Q1
$4.22M Buy
94,268
+10,593
+13% +$474K ﹤0.01% 2428
2018
Q4
$4.02M Buy
83,675
+10,414
+14% +$500K ﹤0.01% 2349
2018
Q3
$4.89M Buy
73,261
+2,283
+3% +$152K ﹤0.01% 2371
2018
Q2
$3.34M Buy
70,978
+3,870
+6% +$182K ﹤0.01% 2557
2018
Q1
$3.79M Sell
67,108
-2,361
-3% -$133K ﹤0.01% 2413
2017
Q4
$3.44M Buy
69,469
+6,583
+10% +$326K ﹤0.01% 2442
2017
Q3
$4.78M Buy
62,886
+14,248
+29% +$1.08M ﹤0.01% 2232
2017
Q2
$4.58M Buy
48,638
+1,958
+4% +$184K ﹤0.01% 2203
2017
Q1
$3.71M Buy
46,680
+5,170
+12% +$411K ﹤0.01% 2286
2016
Q4
$3.46M Buy
41,510
+1,138
+3% +$94.7K ﹤0.01% 2297
2016
Q3
$4.52M Buy
40,372
+577
+1% +$64.5K ﹤0.01% 2031
2016
Q2
$4.41M Sell
39,795
-325
-0.8% -$36K ﹤0.01% 1999
2016
Q1
$4.19K Buy
40,120
+3,744
+10% +$391 ﹤0.01% 1976
2015
Q4
$2.93M Buy
36,376
+735
+2% +$59.2K ﹤0.01% 2224
2015
Q3
$2.47M Buy
35,641
+649
+2% +$45K ﹤0.01% 2298
2015
Q2
$3.43M Buy
34,992
+6,360
+22% +$623K ﹤0.01% 2157
2015
Q1
$2.8M Buy
28,632
+990
+4% +$96.9K ﹤0.01% 2223
2014
Q4
$3.04M Buy
27,642
+395
+1% +$43.5K ﹤0.01% 2141
2014
Q3
$3.22M Buy
27,247
+2,173
+9% +$257K ﹤0.01% 2051
2014
Q2
$3.25M Buy
25,074
+6,476
+35% +$840K ﹤0.01% 2079
2014
Q1
$2.97M Buy
18,598
+1,771
+11% +$283K ﹤0.01% 2103
2013
Q4
$2.34M Buy
16,827
+2,531
+18% +$352K ﹤0.01% 2201
2013
Q3
$1.42M Buy
14,296
+1,119
+8% +$111K ﹤0.01% 2377
2013
Q2
$504K Buy
+13,177
New +$504K ﹤0.01% 2874